Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome.

Katja N De PaepeCiska-Anne Van KeerberghenGiorgio Maria AgazziFrederik De KeyzerOlivier GheysensOliver BechterPascal WolterDaan DierickxAnn JanssensGregor VerhoefRaymond OyenMichel KooleVincent Vandecaveye

Published in: Radiology. Imaging cancer (2021)

Quantitative WB-DW MRI after only one cycle of immunochemotherapy predicts DFS in aggressive NHL and is noninferior to routinely performed interim and end-of-treatment 18F-FDG PET/CT.Keywords: MR-Diffusion Weighted Imaging, Lymphoma, Oncology, Tumor Response, Whole-Body ImagingSupplemental material is available for this article.© RSNA, 2021.

Keyphrases

contrast enhanced
diffusion weighted
diffusion weighted imaging
magnetic resonance imaging
prognostic factors
magnetic resonance
computed tomography
high resolution
mass spectrometry
replacement therapy